Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-028409
Filing Date
2012-05-14
Accepted
2012-05-14 12:34:29
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v312153_10q.htm 10-Q 346632
2 EXHIBIT 31.1 v312153_ex31-1.htm EX-31.1 8699
3 EXHIBIT 31.2 v312153_ex31-2.htm EX-31.2 8440
4 EXHIBIT 32.1 v312153_ex32-1.htm EX-32.1 5000
  Complete submission text file 0001144204-12-028409.txt   1536034

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mdgn-20120331.xml EX-101.INS 158327
6 XBRL TAXONOMY EXTENSION SCHEMA mdgn-20120331.xsd EX-101.SCH 17700
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgn-20120331_cal.xml EX-101.CAL 27493
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgn-20120331_def.xml EX-101.DEF 59224
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgn-20120331_lab.xml EX-101.LAB 133162
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgn-20120331_pre.xml EX-101.PRE 73240
Mailing Address TERADION BUSINESS PK. P.O. BOX 14 MISGAV L3 20179
Business Address TERADION BUSINESS PK. P.O. BOX 14 MISGAV L3 20179 1-646-239-1690
MEDGENICS, INC. (Filer) CIK: 0001138776 (see all company filings)

EIN.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35112 | Film No.: 12837464
SIC: 2836 Biological Products, (No Diagnostic Substances)